Glucose & Insulin

Poorly Controlled Blood Sugar Increases Risk of Death for COVID-19

Researchers have found that people with diabetes and poorly managed hyperglycemia who are hospitalized for COVID-19 have a death rate, and longer length of hospital stay, four times higher than people without these conditions. Read more

Too Much Glucagon May Contribute to Type 2

Glucagon is a pancreatic hormone which contributes to glucose production. A new study found that patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. Read more

Generic Lilly Insulins Now Available at Half Price

“Authorized generic” versions of two popular insulins made by Eli Lilly are now available to order by U.S. pharmacies, with list prices 50% lower than the Lilly’s branded equivalents. The two insulins are insulin lispro protamine and insulin lispro injectable suspension (Humalog Mix 75/25 KwikPen) and insulin lispro injection 100 U/mL (Humalog Junior KwikPen). Read […]

Can Some Insulins Increase Breast Cancer Risk?

A study conducted among Medicare patients looked at whether some forms of insulin and breast cancer risk may be linked in elderly women with diabetes. Read more

Saliva Tests instead of Fingersticks?

Scottish researchers have developed a test using a diabetes patient’s saliva as potential less invasive and painful alternative to the current practice of monitoring blood glucose. Lab tests of the saliva process had an accuracy rate of 95.2%. Read more

Lilly Caps Insulin Prices in Response to Coronavirus

Drugmaker Eli Lilly has announced it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the United States, many of whom face increased financial difficulties due to the COVID-19 outbreak. This new co-pay scheme covers most of Lilly’s insulins, including the Humalog injection, and is available to people […]

How Can You Have Low Blood Sugar but High A1c?

A diabetes educator shares a real-life example of how misunderstanding insulin dosing almost led to a disaster. A patient who had had diabetes for over a year visited the office complaining that her A1c was high, but when she checked her blood sugars, they were low almost every day, and she’s had many hypoglycemic reactions. […]

Many with Type 2 Delay Insulin, to their Cost

More than 40% of people with type 2 diabetes initially decline insulin therapy recommended by their doctors, and compared with those who began insulin therapy, those who refused had worse glycemic control, and took longer to achieve healthier blood sugar levels , according to new research from Brigham and Women’s Hospital. Read more

Dexcom & DreaMed Diabetes to Collaborate on Insulin Delivery Platform

The collaboration enables a seamless data transfer of data from Dexcom’s CGM (continuous glucose monitoring) devices into DreaMed Advisor, a platform designed to assist healthcare professionals in the optimization of patient-specific insulin therapy for people with diabetes by analyzing information from CGM, self-monitoring blood glucose, and insulin delivery devices. Read more

Researchers See Paradox in Diabetes Management

Overtreatment and undertreatment can both pose serious problems for people with diabetes. It’s a fine line between enough treatment to prevent the complications caused by high blood sugars, and too much treatment, which can cause blood sugar levels to fall dangerously low (hypoglycemia). Individualized treatment could help avoid these issues. Read more

Coin-Sized Smart Insulin Patch Could Help Treat Diabetes

Researchers have made progress in developing a smart insulin-delivery patch that may one day monitor and manage glucose levels in people with diabetes, and deliver the necessary insulin dosage. The adhesive patch is about the size of a quarter, is simple to manufacture, and is intended for once-a-day use. Read more

Link Between Severe Low Glucose and Brain Health

Studies have shown that patients who have type 1 diabetes and severe hypoglycemia can experience a decrease in cognitive functions including visual perception, speed of information processing, attention span, psychomotor efficiency, and mental flexibility.  Read more

How can the High Cost of Insulin in the US be Brought Down?

Reducing the high cost of insulin in the United States will require multiple changes to the current complex drug pricing system, Mayo Clinic hematologist S. Vincent Rajkumar, MD, argues in a new commentary, The High Cost of Insulin in the United States: An Urgent Call to Action. Read more

Novo Nordisk Offers Free Insulin

Novo Nordisk has announced it would offer a free, one-time supply of insulin to people in immediate need and at risk of rationing the medication. Patients with prescription can get a free, one-time supply of up to three vials or two packs of pens of its insulin. Read more

FDA Approves Faster-Acting Insulin for Children

The U.S. Food and Drug Administration (FDA) has approved Fiasp (insulin aspart injection; Novo Nordisk), a rapid-acting human insulin analog, for use in children with diabetes. Fiasp has an additional ingredient, niacinamide, which increases absorption speed, and was previously approved for use in adults and in insulin pumps. Read more

FDA Approval for First Automated Insulin Dosing Controller

The Tandem t:slim X2 insulin pump will not only discontinue the delivery of insulin if blood sugars detected by a CGM record low blood sugars, but will also calculate the amount of insulin needed and inject that insulin when needed for elevated blood sugars. Read more

Oral Insulin May Soon Be Reality

A Phase 2b study in patients with type 2 diabetes (T2DM) was completed for what looks likely to be the first oral form of insulin (ORMD-0801). The developing company, Oramed Pharmaceuticals’, CEO Nadav Kidron and Dr. Joel Neutel, Principal Investigator of the study discuss the results. Read more

Hospitals Fail to Implement Insulin Best Practices

According to recent research, greater than 75% of hospitals in the United States follow outdated insulin management protocols that are no longer recommended by the American Diabetes Association, American Association of Clinical Endocrinologists, and Society of Hospital Medicine. Read more

New Biosimilar Insulins May Be Coming, Thanks to FDA

A new US Food and Drug Administration (FDA) policy may help bring biosimilar insulins to market more quickly. (Biosimilars are biologic medical products that are highly similar to another already approved biological medicine.) However, analysts say there is no guarantee that the products will be significantly less expensive than branded insulins. Read more

Freestyle Libre Can Help People with Diabetes & Dementia

The FreeStyle Libre wearable monitor could be of great benefit in helping older people with diabetes and memory loss manage their condition better, according to researchers have said. The device automatically reads glucose levels without a fingerstick, making diabetes easier to manage. Read more